Search results for "Myocardial infarction"
Troponin concentration may help stratify risk in those with stable ischemic heart disease and diabetes
Researchers used a high-sensitivity assay to measure cardiac troponin T concentration at baseline, then analyzed whether it was associated with a composite end point (death from cardiovascular causes, myocardial infarction, or stroke).
https://immattersacp.org/weekly/archives/2015/08/18/4.htm
18 Aug 2015
Low-dose aspirin's effects on survival may come with caveats
A trial was stopped early after researchers determined that continued aspirin use appeared to yield no benefit.
https://immattersacp.org/weekly/archives/2018/09/18/2.htm
18 Sep 2018
RSV vaccine approved; several actions on opioids
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023
New guidelines for dual antiplatelet therapy in patients with CAD
Clinicians should weigh ischemic risks and bleeding risks before adding a P2Y12 inhibitor to aspirin monotherapy or prolonging dual antiplatelet therapy, among other recommendations.
https://immattersacp.org/weekly/archives/2016/04/05/2.htm
5 Apr 2016
As little as 1 week of NSAID use may be associated with increased risk of acute MI, review finds
Use for eight to 30 days was particularly harmful with more than 1,200 mg of ibuprofen per day, more than 750 mg of naproxen per day, and more than 25 mg of rofecoxib per day.
https://immattersacp.org/weekly/archives/2017/05/16/4.htm
16 May 2017
Folic acid supplementation may help prevent first stroke in high-risk patients with hypertension
Among patients with low platelet count and high total homocysteine levels, receiving folic acid reduced the risk of first stroke by 73%, whereas there was no significant effect of folic acid among low-risk patients.
https://immattersacp.org/weekly/archives/2018/05/08/2.htm
8 May 2018
Aspirin associated with fewer CV events, more major bleeding in healthy patients, review finds
When weighing the risks and benefits of aspirin for primary cardiovascular (CV) prevention in individual patients, clinicians must also consider other interventions that may lower risk, an accompanying editorial said.
https://immattersacp.org/weekly/archives/2019/01/29/1.htm
29 Jan 2019
NSAIDs may increase bleeding, CV events when combined with antiplatelet or anticoagulant agents post-MI
Nonsteroidal anti-inflammatory drugs (NSAIDs) were associated with increased risk of bleeding and thrombotic events, even during short-term treatment, among patients receiving antithrombotic therapy after myocardial infarction (MI), a study found.
https://immattersacp.org/weekly/archives/2015/03/03/2.htm
3 Mar 2015
Clopidogrel associated with decreased benefit in diabetics post-MI
Diabetics benefit less from receiving clopidogrel after myocardial infarction (MI) than non-diabetics, a study found.
https://immattersacp.org/weekly/archives/2012/09/11/4.htm
11 Sep 2012
Perioperative medicine changed in the pandemic
In the face of a lack of guidance on perioperative medicine during the COVID-19 pandemic, many hospitals are developing their own guidelines on timing of surgery after infection in vaccinated patients.
https://immattersacp.org/archives/2022/05/perioperative-medicine-changed-in-the-pandemic.htm
1 May 2022